Compare CRVO & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRVO | BODI |
|---|---|---|
| Founded | 2001 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.1M | 83.5M |
| IPO Year | N/A | N/A |
| Metric | CRVO | BODI |
|---|---|---|
| Price | $7.33 | $11.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $21.50 | $8.00 |
| AVG Volume (30 Days) | 60.7K | ★ 102.7K |
| Earning Date | 11-10-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $6,159,786.00 | ★ $282,565,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.92 | $3.38 |
| 52 Week High | $16.94 | $12.33 |
| Indicator | CRVO | BODI |
|---|---|---|
| Relative Strength Index (RSI) | 39.20 | 61.49 |
| Support Level | $7.61 | $10.18 |
| Resistance Level | $8.55 | $12.33 |
| Average True Range (ATR) | 0.59 | 1.07 |
| MACD | -0.17 | -0.12 |
| Stochastic Oscillator | 11.71 | 60.07 |
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.